S.Amdt. 3285

SA 3285. Mrs. BLACKBURN submitted an amendment intended to be
proposed by her to the concurrent resolution S. Con. Res. 14, setting
forth the congressional budget for the United States Government for
fiscal year 2022 and setting forth the appropriate budgetary levels for
fiscal years 2023 through 2031; which was ordered to lie on the table;
as follows:

At the end of title III, add the following:

SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO RELATING
TO SUPPORTING THE ADVANCEMENT, DEVELOPMENT, AND
IMPLEMENTATION OF ADVANCED AND CONTINUOUS
PHARMACEUTICAL MANUFACTURING.

The Chairman of the Committee on the Budget of the Senate
may revise the allocations of a committee or committees,
aggregates, and other appropriate levels in this resolution,
and make adjustments to the pay-as-you-go ledger, for one or
more bills, joint resolutions, amendments, amendments between
the Houses, motions, or conference reports relating to
relating to supporting the advancement, development, and
implementation of advanced and continuous pharmaceutical
manufacturing, which may include designating national centers
of excellence, by the amounts provided in such legislation
for those purposes, provided that such legislation would not
increase the deficit over either the period of the total of
fiscal years 2022 through 2026 or the period of the total of
fiscal years 2022 through 2031.
______